does anthem blue cross cover glp-1 Is this a hard no?

Thats where physical therapy comes in

Liraglutide, marketed under the brand names Victoza for diabetes management and Saxenda for weight management, is a versatile GLP-1 receptor agonist with a distinct focus on weight loss

Phase 3 outcomes will be critical to confirm sustained efficacy, cardiovascular benefit, tolerability at scale, and real-world adherence

Similarly, patients with Multiple Endocrine Neoplasia syndrome type 2 should not use this medication, as this genetic condition predisposes individuals to medullary thyroid carcinoma among other endocrine tumors

Inflammation is closely linked to oxidative stress and cancer

15, 2024), [41] Id